Skip to main content
Clinical Trials/JPRN-jRCTs032220521
JPRN-jRCTs032220521
Active, Not Recruiting
N/A

A validative clinical study comparing non-invasive blood glucose measurement by mid-infrared spectroscopy and venous blood glucose in diabetic patients

ishimura Rimei0 sites410 target enrollmentDecember 19, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
ishimura Rimei
Enrollment
410
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 19, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ishimura Rimei

Eligibility Criteria

Inclusion Criteria

  • Inpatients who meet all of the following selection criteria will be eligible for the study and whose consent has been obtained
  • 1\.Patients who are able to have at least 5 blood samples taken and blood glucose level measured by the test device.
  • 2\. Age Patients who are at least 18 years old at the time consent is obtained.
  • 3\. Gender Any gender
  • 4\. Patients who have been fully informed of the study and who have given written consent of their own free will.
  • 5\. Patients who possess SMBG equipment (SMBG capable of acquiring data up to 15 times every 10 minutes) or wear CGM equipment (FreestyleLibre) (Measurement B only)

Exclusion Criteria

  • Patients who meet at least one of the following exclusion criteria will be excluded.
  • (1\) Patients who require immediate treatment due to changes in blood glucose levels
  • (2\) Patients who are judged by the principal investigator (subinvestigator) to be inappropriate to participate in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials